Hi, what are you looking for?

According to the insight partners new research study on “Joint Pain Injection Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Drug, Joint Type, and Distribution Channel,” the market is expected to reach US$ US$ 6,996.88 million by 2028 from US$ 3,667.45 million in 2020; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028.

Companies operating in the joint pain injection market are undertaking an increasing number of research and development activities to introduce more innovative products. For instance, in April 2017, Bioiberica S.A.U., Spain, launched the Hialsorb Intraarticular hyaluronic acid injection to treat pain and inflammation associated with osteoarthritis (OA). The injection has the ability to restore the viscosity and elasticity of synovial fluid, thereby decreasing pain and inflammation as well as increasing mobility of the affected organ and reducing friction between bones.

Download sample PDF Copy of Joint pain injection Market study @ https://www.theinsightpartners.com/sample/TIPRE00003536/

Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx are among the leading companies operating in the joint pain injection market.

Additionally, in November 2017, Flexion Therapeutics Inc. launched Zilretta, an intra-articular injection for OA-related knee pain. It is a non-opioid medicine that has Flexion’s proprietary microsphere technology and offers pain relief for 12 weeks among the patients with OA of knee. Furthermore, in July 2019, Teva Pharmaceutical Industries Ltd launched 1% Sodium Hyaluronate for the treatment of patients with OA-related knee pain; the product is especially prescribed to patients who couldn’t respond well to conservative non-pharmacologic therapy and simple analgesics. Such increasing number of product developments and launches are emerging as an important trend in the joint pain injection market.

Geographically, the joint pain injection market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). North America held the largest market share in 2020. In North America, the US is the largest market for joint pain injection. The market growth in the region is attributed to the presence of key market players and their engagement in product developments. In addition, the growing prevalence of orthopedic diseases, presence of well-developed healthcare infrastructure, and availability of effective reimbursement coverage are among the prominent factors propelling the market growth in North America.

Below is the list of the growth strategies done by the players operating in the joint pain injection market:

In Mar-2021 – Collaboration of Seikagaku Corporation and Ono Pharmaceutical Co., Ltd. announced marketing and manufacturing approval for its JOYCLU, intra-articular injection for knee and hip joint pain in Japan market.

In Mar-2021 – Bioventus announced acquisition of Bioness, Inc., a significant player in neuromodulation and rehabilitation medical devices market. Through this acquisition, Bioventus will get opportunity to consolidate its product portfolio in implantable and external neuromodulation systems, software-based programs for various therapies, and healthcare robotic systems.

in May-2020 – OrthogenRx, Inc announced launch of the TriVisc Patient Assistance Program and the TriVisc Direct Purchase Program to spread product awareness. Moreover, company promoted their product with strategic pricing.

In Jan-2020 – Anika Therapeutics announced its plan to acquire Arthrosurface and Parcus Medical. This strategic acquisition will help the company extend its regenerative therapy portfolio and hyaluronic acid (HA) technology platform.

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods – https://www.theinsightpartners.com/buy/TIPRE00003536/

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

The UK government was accused of a “cover-up” after the controversial 2020 appointment of a Russian-born newspaper baron to parliament.

Ukraine says more than 1,000 fighers are holding out in the Azovstal steel works in the ruined city of Mariupol - Copyright AFP TIMOTHY...

A picture taken on January 24, 2022 shows Abu Dhabi, capital of the UAE. — © AFP Anatolii STEPANOVShatha YAISHThe United Arab Emirates’ President...

The foreign ministers of Group of Seven industrialised nations are meeting in northern Germany - Copyright AFP MOHAMMED ABEDThe G7 group of industrialised nations...

COPYRIGHT © 1998 - 2022 DIGITAL JOURNAL INC. Digital Journal is not responsible for the content of external sites. Read more about our external linking.